Saturday 17 October 2026
Export WEAV’s income statement to Excel — free account
Weave Communications, Inc.
WEAV Healthcare Health Information Services
Weave Communications, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $239.0 million, up 17.0% from fiscal 2024. In the quarter to June 2026, revenue grew 15.5%, EPS grew 54.6%, free cash flow grew 94.3% and total debt rose 4.91%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
7.39
0.00
0.00%
Follow WEAV
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.85 | 1.46 | 2.42 | 2.25 | |
P/FCF ratio |
43.28 | 53.40 | 45.04 | 35.41 | |
P/Operating CF |
46.58 | (63.63) | 92.74 | 85.13 | |
P/B ratio |
5.61 | 4.36 | 7.03 | 6.57 | |
Price to Tangible BV |
9.72 | 7.72 | 12.65 | 12.40 | |
EV/Sales |
1.61 | 1.23 | 2.15 | 1.97 | |
EV/EBITDA |
35.22 | 65.79 | 0.00 | 0.00 | |
EV/Operating CF |
24.68 | 25.44 | 29.29 | 25.19 | |
EV/FCF |
37.72 | 45.11 | 39.94 | 31.03 | |
Quick Ratio |
0.99 | 0.95 | 1.02 | 1.02 | |
Current Ratio |
1.25 | 1.24 | 1.24 | 1.24 | |
Net Debt/EBITDA |
(16.21) | (26.88) | (12.59) | 70.09 | |
Debt/Assets |
3.48% | 3.12% | 3.00% | 3.07% | |
Debt/Equity |
0.09 | 0.08 | 0.08 | 0.08 | |
Asset Turnover |
1.25 | 1.27 | 1.20 | 1.15 | |
Operating CF/Net income |
(2.41) | 0.99 | (3.38) | (0.70) | |
Capex/Depreciation |
(0.18) | (0.17) | (0.23) | (0.13) | |
Interest Coverage |
(10.44) | (16.32) | (5.40) | (24.44) | |
Research and Development Expense of Revenue |
17.85% | 16.51% | 12.93% | 21.39% | |
Selling, General and Administrative Expense of Revenue |
60.68% | 65.26% | 63.14% | 65.48% | |
Intangible Assets out of Total Assets |
0.17 | 0.18 | 0.18 | 0.18 | |
Share Based Compensation of Revenue |
10.41% | 10.89% | 6.26% | 16.17% | |
Graham Net Nets |
(0.04) | (0.06) | (0.04) | (0.05) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(4.17%) | (6.71%) | (4.74%) | (6.44%) | |
Free Cash Flow Yield |
2.31% | 1.87% | 2.22% | 2.82% | |
Revenue per Share |
0.85 | 0.83 | 0.83 | 0.79 | |
Operating CF per Share |
0.13 | (0.07) | 0.08 | 0.08 | |
Capex per Share |
(0.02) | (0.02) | (0.02) | (0.01) | |
Free Cash Flow per Share |
0.11 | (0.09) | 0.06 | 0.07 | |
Cash per Share |
0.99 | 0.93 | 1.07 | 1.04 | |
Shareholders Equity per Share |
1.07 | 1.06 | 1.08 | 1.02 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.07 | 1.06 | 1.08 | 1.02 | |
Free Cash Flow |
8.70 | (7.12) | 4.40 | 5.05 | |
Working Capital |
20.73 | 19.61 | 20.40 | 20.04 | |
Capital Expenditures |
(1.54) | (1.42) | (1.85) | (1.02) | |
Net Current Asset Value |
(18.91) | (20.33) | (20.59) | (24.89) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.02 | 0.03 | 0.02 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
3.92 | 3.88 | 4.05 | 6.32 | |
Average Payables |
7.01 | 5.74 | 7.77 | 6.86 | |
Average Assets |
206.47 | 196.30 | 198.45 | 199.25 | |
Average Common Equity |
81.92 | 75.93 | 74.68 | 73.73 |
Columns are period end dates